ASTAL LABORATORIES LIMITED Share Price

BSE: 512600

S Cap

₹ 87.07

-₹1.21 (-1.37%)

Last updated 14 Aug, 2026, 14:57 IST

ASTAL LABORATORIES LIMITED Share Price Today

As of 14 Aug 2026, ASTAL LABORATORIES LIMITED share price is ₹87.07. The stock opened at ₹87.72, compared to its previous close of ₹88.28. During today's trading session, ASTAL LABORATORIES LIMITED share price moved in the range of ₹86.00 to ₹88.32, with an average price of ₹87.16 for the day. Looking at its last 52-week, the stock has touched a low of ₹60.45 and a high of ₹103.20.

₹86.00

1.37% down today

₹88.32

1D LOW

1D HIGH

Latest Earning

Op Profit TrendUp by 166.45% QoQ

Latest Earning

Net Profit TrendUp by 225.42% QoQ

Latest Earning

Revenue TrendUp by 156.60% QoQ

Stock Performance

OutperformingBeat Nifty by 0.92 % in last 1 month

ASTAL LABORATORIES LIMITED Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹5,20,941+₹20,941 (+4.19%)

3 Year

₹14,25,974+₹9,25,974 (+185.19%)

5 Year

₹40,31,019+₹35,31,019 (+706.20%)

₹70.63₹105.93

Circuit Low

Circuit High

₹60.45₹103.20

52-Week Low

52-Week High

Circuit

₹70.63

₹105.93

52-week

₹60.45

₹103.20

About ASTAL LABORATORIES LIMITED

ISIN

INE307N01014

Sector Market Cap

₹ 386.66 Cr

Astal Laboratories Limited is an India-based company, which is engaged in the manufacturing and sale of pharmaceutical intermediates and bulk drugs. The Company is engaged in manufacturing fine chemicals, specialty chemicals and pharmaceutical intermediates. The Company’s products include HF Acid (2-Chloro-1,3-Bis (Dimethylamino) Trimethinium Hexafluorophosphate); 4-Methyl Sulphonyl Phenyl Acetic acid, (1R,3R)-methyl 1-(benzo[d][1,3] dioxol-5-yl)- 2,3,4,9-tetrahydro-1 H-pyrido[3,4-b]indole-3- carboxylate hydrochloride; L-Valine methyl ester Hydrochloride (LVMH); L-Valine benzyl ester Hydrochloride; N-[(2-Cyanobiphenyl-4-methyl)- L-Valine methyl ester Hydrochloride; D-Tryptophan Methyl Ester Hydrochloride; Moc-L-valine (N-(Methoxycarbonyl)-L-valine); 2-Ethoxyethyl-4-methylbenzene sulfonate; 2 Piperidin-4-yl-1H-benzoimidazole; Alpha, alpha-Dimethyl Phenyl Acetic Acid (2-Methyl-2-phenylpropionic acid); 2-(4-bromophenyl)-2-methylpropionic acid; Methyl 2,2-dimethylphenylacetate, and others.

ASTAL LABORATORIES LIMITED Financial Highlights

Revenue: ASTAL LABORATORIES LIMITED reported revenue of ₹249.35 crore in FY26 vs ₹64.36 crore in FY25. It showed an increase of 287.43% on a yearly basis.
Operating Profit: ASTAL LABORATORIES LIMITED reported an operating profit of ₹17.73 crore in FY26 vs ₹11.98 crore in FY25. It showed an increase of 48.00% on a year-on-year basis.
Net Profit: ASTAL LABORATORIES LIMITED reported a net profit of ₹14.71 crore in FY26 vs ₹8.93 crore in FY25. It showed an increase of 64.73% on a yearly basis.

ASTAL LABORATORIES LIMITED Quarterly Result Highlights

ASTAL LABORATORIES LIMITED reported revenue of ₹134.15 crore in Mar 2026, compared with ₹52.28 crore in Dec 2025, representing an increase of 156.60% on a quarter-on-quarter (QoQ) basis.
ASTAL LABORATORIES LIMITED reported an operating profit of ₹8.34 crore in Mar 2026, compared with ₹3.13 crore in Dec 2025, representing an increase of 166.45% on a quarter-on-quarter (QoQ) basis.
ASTAL LABORATORIES LIMITED reported a profit of ₹7.68 crore in Mar 2026, compared with ₹2.36 crore in Dec 2025, reflecting an increase of 225.42% on a QoQ basis.

Know more

Promoters

4.53%

FII

0.00%

Other DII

0.00%

Retail and other

95.47%

Mutual funds

0.00%

Foreign institutions - FII

FII shareholding by period
Dec 2025	0.00%
Mar 2026	0.00%
May 2026	0.00%
Jun 2026	0.00%

Mkt Cap Cr

386.66

P/E

47.72

P/B

1.16

ROE

2.48%

D/E

0.04

ROCE

3.61%

Div. Yield

0.00%

EPS(TTM)

4.76

Turnover

0.47

EV/EBITDA

30.16

Net Margin

0.00%

Op. Margin

0.00%

ROA

2.03%

Quick Ratio

0.00

Curr. Ratio

1.74

Mkt Cap Cr

386.66

P/E

47.72

P/B

1.16

ROE

2.48%

D/E

0.04

ROCE

3.61%

Div. Yield

0.00%

EPS(TTM)

4.76

Turnover

0.47

EV/EBITDA

30.16

Net Margin

0.00%

Op. Margin

0.00%

ROA

2.03%

Quick Ratio

0.00

Curr. Ratio

1.74

Based on fundamentals, this stock's

Performance

Excellent

Astal Lab outperforming all market indices

Valuation

Overvalued

Astal Lab appears overvalued compared to its peers

Earnings

Excellent

Astal Lab revenue, operating profit and net profit are growing

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,66,155.00	38.47	5.58	13.74%	0.61	17.33%	93.24	0.82%	0.48	10.90
Divis Laboratories	2,25,648.00	77.15	13.46	15.32%	0.00	19.56%	629.49	0.35%	0.55	98.19
Torrent Pharmaceuticals	1,86,000.00	86.03	22.06	25.49%	1.69	13.85%	222.76	0.69%	0.49	58.70
Zydus Lifesciences	1,17,007.00	25.48	4.32	18.59%	0.31	17.35%	237.30	0.09%	0.33	35.38
Cipla	1,18,027.00	35.17	3.43	11.27%	0.00	14.95%	423.36	0.89%	0.45	43.52
Lupin	1,03,380.00	18.62	4.61	23.76%	0.04	24.88%	659.05	0.80%	0.57	129.18
Mankind Pharma	99,862.40	48.30	6.13	11.74%	0.34	13.13%	397.02	0.04%	0.44	49.37
Dr. Reddy's Laboratories	1,00,662.00	31.62	2.64	11.07%	0.18	12.54%	377.96	0.66%	0.41	38.68
Laurus Labs	99,474.20	91.23	18.77	16.77%	0.40	16.14%	97.20	0.11%	0.67	13.72
Aurobindo Pharma	96,215.60	25.93	2.54	9.25%	0.19	11.76%	391.14	0.24%	0.38	41.58

ASTAL LABORATORIES LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2026
Revenue	64.36	249.35
Operating profit	11.98	17.73
Net profit	8.93	14.71

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹64.23	₹23.65	₹3.43	₹0.00
Other Income	₹0.13	₹0.01	₹0.18	₹0.21
Total Revenue	₹64.36	₹23.66	₹3.61	₹0.21
Total Expenses	₹52.38	₹22.57	₹3.57	₹0.23
Profit Before Tax	₹11.98	₹1.09	₹0.03	-₹0.02
Tax	₹3.05	₹0.30	₹0.02	₹0.00
Profit After Tax	₹8.93	₹0.78	₹0.02	-₹0.02
EPS - Basic	₹9.08	₹1.55	₹0.04	-₹0.04
EPS - Diluted	₹8.04	₹1.55	₹0.04	-₹0.04

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹11.98	₹1.09	₹0.03	-₹0.02
Income before WC changes	₹12.78	₹1.11	-₹0.14	-₹0.21
Change in Assets	-₹23.36	-₹14.62	-₹5.95	₹0.03
Change in Liabilities	-₹1.63	₹7.96	₹4.66	-₹0.06
Change in WC	-₹24.99	-₹6.66	-₹1.29	-₹0.04
Cash flow from Operations	-₹12.52	-₹5.58	-₹1.44	-₹0.25
Cash flow from Investing	-₹7.81	-₹6.11	₹1.50	₹0.24
Cash flow from Financing	₹3.29	₹17.68	₹0.00	₹0.00
Total Cash Flow	-₹17.04	₹5.99	₹0.07	-₹0.01
Cash (Start of the year)	₹6.08	₹0.08	₹0.02	₹0.03
Cash (End of the year)	-₹10.96	₹6.08	₹0.08	₹0.02

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹17.70	₹9.89	₹3.79	₹5.13
Current Assets	₹45.64	₹26.73	₹6.11	₹0.10
Total Assets	₹63.34	₹36.61	₹9.91	₹5.23
Current Liabilities	₹26.77	₹13.01	₹4.73	₹0.07
Net Current Asset	₹18.87	₹13.72	₹1.38	₹0.03
Non-Current Liabilities	₹0.57	₹0.26	₹0.00	₹0.00
Equity Capital	₹35.99	₹23.34	₹5.18	₹5.16
Total Equity & Liabilities	₹63.34	₹36.61	₹9.91	₹5.23